| November |
| November 14, 2008 |
|
VALEANT PHARMACEUTICALS ACQUIRES DERMATECH
|
| November 12, 2008 |
|
VALEANT PHARMACEUTICALS TO PRESENT AT LAZARD CAPITAL MARKETS 5TH ANNUAL HEALTHCARE CONFERENCE
|
| November 07, 2008 |
|
VALEANT PHARMACEUTICALS TO PRESENT AT 2008 CREDIT SUISSE PHOENIX HEALTH CARE CONFERENCE
|
| November 06, 2008 |
|
VALEANT PHARMACEUTICALS REPORTS THIRD QUARTER FINANCIAL RESULTS
|
| October |
| October 24, 2008 |
|
VALEANT PHARMACEUTICALS ANNOUNCES PROMOTION AGREEMENT FOR DIASTAT® ACUDIAL
|
| October 22, 2008 |
|
VALEANT PHARMACEUTICALS TO ANNOUNCE 2008 THIRD QUARTER RESULTS ON NOVEMBER 6, 2008
|
| October 17, 2008 |
|
VALEANT PHARMACEUTICALS AND GLAXOSMITHKLINE COMPLETE WORLDWIDE COLLABORATION AGREEMENT FOR RETIGABINE
|
| October 16, 2008 |
|
VALEANT PHARMACEUTICALS COMPLETES ACQUISITION OF CORIA LABORATIES, LTD.
|
| September |
| September 17, 2008 |
|
VALEANT PHARMACEUTICALS SIGNS AGREEMENT TO ACQUIRE CORIA LABORATORIES, LTD.
|
| September 15, 2008 |
|
VALEANT ANNOUNCES PRESENTATION OF RETIGABINE DATA AT THE 8TH EUROPEAN CONGRESS ON EPILEPTOLOGY
|
| September 12, 2008 |
|
VALEANT PHARMACEUTICALS COMPLETES SALE OF CERTAIN EUROPEAN OPERATIONS TO MEDA AB
|
| August |
| August 28, 2008 |
|
VALEANT PHARMACEUTICALS AND GLAXOSMITHKLINE ANNOUNCE WORLDWIDE COLLABORATION AGREEMENT FOR RETIGABINE
|
| August 22, 2008 |
|
VALEANT PHARMACEUTIALS TO PRESENT AT UBS GLOBAL LIFE SCIENCES CONFERENCE
|
| August 11, 2008 |
|
VALEANT PHARMACEUTICALS REPORTS SECOND QUARTER FINANCIAL RESULTS
|
| August 07, 2008 |
|
VALEANT ANNOUNCES AGREEMENT TO ENTER INTO JOINT VENTURE WITH MEDA
|
| August 04, 2008 |
|
VALEANT SELLS CERTAIN BUSINESS OPERATIONS IN EUROPE FOR $392 MILLION
|
| July |
| July 21, 2008 |
|
VALEANT PHARMACEUTICALS TO ANNOUNCE 2008 SECOND QUARTER RESULTS ON AUGUST 11, 2008
|
| June |
| June 20, 2008 |
|
VALEANT ANNOUNCES REDEMPTION OF ALL OUTSTANDING 7% SENIOR NOTES DUE 2011
|
| June 17, 2008 |
|
VALEANT PHARMACEUTICALS ANNOUNCES INCREASE IN SHARE REPURCHASE AUTHORIZATION
|
| June 10, 2008 |
|
VALEANT PHARMACEUTICALS DIVESTS ARGENTINA
|
| June 04, 2008 |
|
VALEANT PHARMACEUTICALS TO PRESENT AT GOLDMAN SACHS TWENTY-NINTH ANNUAL GLOBAL HEALTHCARE CONFERENCE
|
| May |
| May 19, 2008 |
|
VALEANT PHARMACEUTICALS TO WEBCAST 2008 ANNUAL MEETING OF STOCKHOLDERS
|
| May 15, 2008 |
|
VALEANT PHARMACEUTICALS ANNOUNCES FDA HAS INITIATED RECONSIDERATION OF GENERIC EFUDEX® APPROVAL
|
| May 13, 2008 |
|
VALEANT ANNOUNCES SUCCESSFUL COMPLETION OF RETIGABINE PHASE III EPILEPSY PROGRAM VALIDATING NOVEL MECHANISM OF ACTION
|
| May 07, 2008 |
|
VALEANT PHARMACEUTICALS REPORTS 2008 FIRST QUARTER FINANCIAL RESULTS
|
| May 05, 2008 |
|
VALEANT PHARMACEUTICALS ANNOUNCES TEMPORARY STAY IN EFUDEX® CASE
|
| May 02, 2008 |
|
VALEANT PHARMACEUTICALS REDUCES HEADCOUNT
|
| April |
| April 24, 2008 |
|
VALEANT PHARMACEUTICALS HIGHLIGHTS TARIBAVIRIN PHASE IIb DATA PRESENTATION AT EUROPEAN ASSOCIATION FOR THE STUDY OF LIVER (EASL) ANNUAL MEETING
|
| April 23, 2008 |
|
VALEANT PHARMACEUTICALS TO ANNOUNCE 2008 FIRST QUARTER RESULTS ON MAY 7, 2008
|
| March |
| March 24, 2008 |
|
VALEANT PHARMACEUTICALS TO HOST STRATEGIC PLAN REVIEW CONFERENCE CALL AND WEBCAST ON MARCH 27, 2008
|
| March 17, 2008 |
|
VALEANT PHARMACEUTICALS REPORTS ENCOURAGING PHASE IIb RESULTS AT TREATMENT WEEK 12 FOR TARIBAVIRIN
|
| March 03, 2008 |
|
VALEANT PHARMACEUTICALS DIVESTS ASIA REGION TO INVIDA PHARMACEUTICAL HOLDINGS FOR $37.8 MILLION
|
| February |
| February 28, 2008 |
|
VALEANT PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2007 RESULTS
|
| February 22, 2008 |
|
VALEANT PHARMACEUTICALS ANNOUNCES ANNUAL STOCKHOLDER MEETING DATE
|
| February 12, 2008 |
|
VALEANT PHARMACEUTICALS REPORTS POSITIVE PHASE III RESULTS FOR RETIGABINE IN RESTORE 1
|
| February 04, 2008 |
|
VALEANT PHARMACEUTICALS ANNOUNCES NEW CEO AND CHAIRMAN
|
| January |
| January 28, 2008 |
|
Valeant Pharmaceuticals to Announce 2007 Fourth Quarter and Year
|
| January 14, 2008 |
|
Valeant Pharmaceuticals Completes Divestment of Hep-C Drug Infergen® to Three Rivers Pharmaceuticals®, LLC
|
